{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:11:48Z","timestamp":1783098708039,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hochschule Bielefeld"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nurs"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with intellectual disabilities suffer from several chronic diseases earlier and more often. At the same time, they use medical screenings to prevent such diseases very irregularly due to a variety of barriers (e.g., social, communicative). Additionally, they often have to manage complex medication regimens characterised by polypharmacy and psychotropic drugs. This complexity often leads to low medication adherence. This study aimed to improve medication adherence and the uptake of medical screenings in adult clients with intellectual disabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a randomised-controlled trial with waiting list and three months follow up in Germany. Clinical nurse specialists provided education to the clients and their caregivers about their medication and medical screenings during two home visits over a three-month period. They analysed the existing medication management and initiated changes where necessary. The control intervention was usual care. Inclusion criteria were: ICD diagnosis F70-79, \u2265 18 years, complex medication regimen (\u2265\u20095 prescribed drugs) understanding of the German language. The primary outcome was medication adherence (MARS-D). Secondary outcomes were the use of medical screenings, complexity of the medication regimen, psychotropic medication, health-related quality of life and health status. Participants were randomised using block randomisation. Raters and analysts were blinded. Analysis was conducted via analysis of covariance (ANCOVA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We recruited 162 participants, of whom 154 could be analysed. In the intervention group adherence changed from 24.7\u2009\u00b1\u20091.1 to 24.9\u2009\u00b1\u20090.4 and in control group from 24.8\u2009\u00b1\u20090.9 to 25.0\u2009\u00b1\u20091.2. A significant difference between the study groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05) was found only for the MRCI-D subscale \u201capplication forms\u201d with a slightly lower complexity in the intervention group (\u03b7\u2009&lt;\u20090.06,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on quantitative evidence nurse-led home visits did not improve medication adherence. In addition, there were no clinically meaningful changes in the secondary outcomes. The study aimed to recruit people with intellectual disabilities from a range of settings, but the vast majority of participants lived in the residential care setting. This resulted in people having high adherence at baseline. Furthermore, the three-month interval between the two visits may have been too short.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register DRKS00014101 (date registered: 17\/08\/2018).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12912-026-04317-4","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:24:51Z","timestamp":1770456291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of nurse-led home visits on medication management and use of medical screenings for adults with intellectual disabilities: a randomised-controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Christian","family":"Grebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Nadolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Palmdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Heitland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Maa\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c4nne-D\u00f6rte","family":"Latteck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","first-page":"e0256294","DOI":"10.1371\/journal.pone.0256294","volume":"16","author":"P Liao","year":"2021","unstructured":"Liao P, Vajdic C, Trollor J, Reppermund S. Prevalence and incidence of physical health conditions in people with intellectual disability - a systematic review. PLoS ONE. 2021;16:e0256294. https:\/\/doi.org\/10.1371\/journal.pone.0256294.","journal-title":"PLoS ONE"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jar.12957","volume":"35","author":"M van den Bemd","year":"2022","unstructured":"van den Bemd M, Cuypers M, Bischoff EWMA, Heutmekers M, Schalk B, Leusink GL. Exploring chronic disease prevalence in people with intellectual disabilities in primary care settings: A scoping review. J Appl Res Intellect Disabil. 2022;35:382\u201398. https:\/\/doi.org\/10.1111\/jar.12957.","journal-title":"J Appl Res Intellect Disabil"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/jrc.2021.2","volume":"27","author":"K Iwanaga","year":"2021","unstructured":"Iwanaga K, Wu JR, Chan F, Rumrill P, Wehman P, Brooke VA, et al. A systematic review of systematic reviews of secondary health conditions, health promotion, and employment of people with intellectual disabilities. Aust J Rehabil Couns. 2021;27:13\u201340. https:\/\/doi.org\/10.1017\/jrc.2021.2.","journal-title":"Aust J Rehabil Couns"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/19315864.2011.651682","volume":"6","author":"J Buckles","year":"2013","unstructured":"Buckles J, Luckasson R, Keefe E. A systematic review of the prevalence of psychiatric disorders in adults with intellectual Disability, 2003\u20132010. J Ment Health Res Intellect Disabil. 2013;6:181\u2013207. https:\/\/doi.org\/10.1080\/19315864.2011.651682.","journal-title":"J Ment Health Res Intellect Disabil"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jar.12654","volume":"33","author":"MG Mazza","year":"2020","unstructured":"Mazza MG, Rossetti A, Crespi G, Clerici M. Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: A systematic review and meta-analysis. J Appl Res Intellect Disabil. 2020;33:126\u201338. https:\/\/doi.org\/10.1111\/jar.12654.","journal-title":"J Appl Res Intellect Disabil"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2015.03.016","volume":"29","author":"J Robertson","year":"2015","unstructured":"Robertson J, Hatton C, Emerson E, Baines S. Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure. 2015;29:46\u201362. https:\/\/doi.org\/10.1016\/j.seizure.2015.03.016.","journal-title":"Seizure"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon C-S, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88:296\u2013303. https:\/\/doi.org\/10.1212\/WNL.0000000000003509.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"4317_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jar.12370","volume":"31","author":"S Ranjan","year":"2018","unstructured":"Ranjan S, Nasser JA, Fisher K. Prevalence and potential factors associated with overweight and obesity status in adults with intellectual developmental disorders. J Appl Res Intellect Disabil. 2018;31(Suppl 1):29\u201338. https:\/\/doi.org\/10.1111\/jar.12370.","journal-title":"J Appl Res Intellect Disabil"},{"key":"4317_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2788.2010.01263.x","volume":"54","author":"U Chauhan","year":"2010","unstructured":"Chauhan U, Kontopantelis E, Campbell S, Jarrett H, Lester H. Health checks in primary care for adults with intellectual disabilities: how extensive should they be? J Intellect Disabil Res. 2010;54:479\u201386. https:\/\/doi.org\/10.1111\/j.1365-2788.2010.01263.x.","journal-title":"J Intellect Disabil Res"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"e43841","DOI":"10.1371\/journal.pone.0043841","volume":"7","author":"DPJ Osborn","year":"2012","unstructured":"Osborn DPJ, Horsfall L, Hassiotis A, Petersen I, Walters K, Nazareth I. Access to cancer screening in people with learning disabilities in the UK: cohort study in the health improvement network, a primary care research database. PLoS ONE. 2012;7:e43841. https:\/\/doi.org\/10.1371\/journal.pone.0043841.","journal-title":"PLoS ONE"},{"key":"4317_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0033-3549(04)50124-3","volume":"117","author":"MA Lewis","year":"2002","unstructured":"Lewis MA, Lewis CE, Leake B, King BH, Lindemann R. The quality of health care for adults with developmental disabilities. Public Health Rep. 2002;117:174\u201384. https:\/\/doi.org\/10.1016\/S0033-3549(04)50124-3.","journal-title":"Public Health Rep"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0004867415587951","volume":"50","author":"KM Chitty","year":"2016","unstructured":"Chitty KM, Evans E, Torr JJ, Iacono T, Brodaty H, Sachdev P, Trollor JN. Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study. Aust N Z J Psychiatry. 2016;50:352\u201362. https:\/\/doi.org\/10.1177\/0004867415587951.","journal-title":"Aust N Z J Psychiatry"},{"key":"4317_CR13","doi-asserted-by":"publisher","unstructured":"Sheehan R, Hassiotis A, Walters K, Osborn D, Strydom A, Horsfall L. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ. 2015;h4326. https:\/\/doi.org\/10.1136\/bmj.h4326.","DOI":"10.1136\/bmj.h4326"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1352\/1944-7558-123.1.72","volume":"123","author":"JD Schoufour","year":"2018","unstructured":"Schoufour JD, Oppewal A, van der Maarl HJK, Hermans H, Evenhuis HM, Hilgenkamp TIM, Festen DA. Multimorbidity and polypharmacy are independently associated with mortality in older people with intellectual disabilities: A 5-Year Follow-Up from the HA-ID study. Am J Intellect Dev Disabil. 2018;123:72\u201382. https:\/\/doi.org\/10.1352\/1944-7558-123.1.72.","journal-title":"Am J Intellect Dev Disabil"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.ridd.2013.02.005","volume":"34","author":"RJ Zaal","year":"2013","unstructured":"Zaal RJ, van der Kaaij ADM, Evenhuis HM, van den Bemt PMLA. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the healthy ageing and intellectual disability study. Res Dev Disabil. 2013;34:1656\u201362. https:\/\/doi.org\/10.1016\/j.ridd.2013.02.005.","journal-title":"Res Dev Disabil"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1352\/1934-9556-52.1.60","volume":"52","author":"JN Stortz","year":"2014","unstructured":"Stortz JN, Lake JK, Cobigo V, Ouellette-Kuntz HMJ, Lunsky Y. Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities. Intellect Dev Disabil. 2014;52:60\u201377. https:\/\/doi.org\/10.1352\/1934-9556-52.1.60.","journal-title":"Intellect Dev Disabil"},{"key":"4317_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/medethics-2012-100899","volume":"40","author":"A Thomson","year":"2014","unstructured":"Thomson A, Roberts P, Bittles A. Navigating the maze: ethics approval pathways for intellectual disability research. J Med Ethics. 2014;40:782\u20136. https:\/\/doi.org\/10.1136\/medethics-2012-100899.","journal-title":"J Med Ethics"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/2042098618782785","volume":"9","author":"M O\u2019Dwyer","year":"2018","unstructured":"O\u2019Dwyer M, McCallion P, McCarron M, Henman M. Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research. Ther Adv Drug Saf. 2018;9:535\u201357. https:\/\/doi.org\/10.1177\/2042098618782785.","journal-title":"Ther Adv Drug Saf"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4140\/TCP.n.2013.793","volume":"28","author":"A Lyles","year":"2013","unstructured":"Lyles A, Culver N, Ivester J, Potter T. Effects of health literacy and polypharmacy on medication adherence. Consult Pharm. 2013;28:793\u20139. https:\/\/doi.org\/10.4140\/TCP.n.2013.793.","journal-title":"Consult Pharm"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2147\/PPA.S314135","volume":"15","author":"JK Schwartz","year":"2021","unstructured":"Schwartz JK, Unni E. Inclusion of people with disabilities in research to improve medication adherence: A systematic review. Patient Prefer Adherence. 2021;15:1671\u20137. https:\/\/doi.org\/10.2147\/PPA.S314135.","journal-title":"Patient Prefer Adherence"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19315864.2014.959216","volume":"8","author":"X Tan","year":"2015","unstructured":"Tan X, Marshall VD, Balkrishnan R, Patel I, Chang J, Erickson SR. Psychotropic medication adherence among Community-Based individuals with developmental disabilities and mental illness. J Ment Health Res Intellect Disabil. 2015;8:1\u201322. https:\/\/doi.org\/10.1080\/19315864.2014.959216.","journal-title":"J Ment Health Res Intellect Disabil"},{"key":"4317_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/1744629519886184","volume":"25","author":"F Sheerin","year":"2021","unstructured":"Sheerin F, Eustace-Cook J, Wuytack F, Doyle C. Medication management in intellectual disability settings: A systematic review. J Intellect Disabil. 2021;25:242\u201376. https:\/\/doi.org\/10.1177\/1744629519886184.","journal-title":"J Intellect Disabil"},{"key":"4317_CR24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/jar.12643","volume":"32","author":"MVA Smith","year":"2019","unstructured":"Smith MVA, Adams D, Carr C, Mengoni SE. Do people with intellectual disabilities understand their prescription medication? A scoping review. J Appl Res Intellect Disabil. 2019;32:1375\u201388. https:\/\/doi.org\/10.1111\/jar.12643.","journal-title":"J Appl Res Intellect Disabil"},{"key":"4317_CR25","doi-asserted-by":"publisher","first-page":"e090876","DOI":"10.1136\/bmjopen-2024-090876","volume":"15","author":"I Ghosh","year":"2025","unstructured":"Ghosh I, Adams D, Auguste P, Brown A, Chaplin E, Flynn S, et al. Challenges of using and managing medication: a meta-ethnography of the experiences and perceptions of people with intellectual disability and people who support them. BMJ Open. 2025;15:e090876. https:\/\/doi.org\/10.1136\/bmjopen-2024-090876.","journal-title":"BMJ Open"},{"key":"4317_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9010024","author":"B Flood","year":"2021","unstructured":"Flood B, Henman MC. Experiences of the medication use process by people with intellectual disabilities. What Pharmacist Should Know! Pharm (Basel). 2021. https:\/\/doi.org\/10.3390\/pharmacy9010024.","journal-title":"What Pharmacist Should Know! Pharm (Basel)"},{"key":"4317_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/jar.12580","volume":"32","author":"A Nabhanizadeh","year":"2019","unstructured":"Nabhanizadeh A, Oppewal A, Boot FH, Maes-Festen D. Effectiveness of medication reviews in identifying and reducing medication-related problems among people with intellectual disabilities: A systematic review. J Appl Res Intellect Disabil. 2019;32:750\u201361. https:\/\/doi.org\/10.1111\/jar.12580.","journal-title":"J Appl Res Intellect Disabil"},{"key":"4317_CR28","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00228-009-0728-2","volume":"65","author":"M Bergqvist","year":"2009","unstructured":"Bergqvist M, Ulfvarson J, Karlsson EA. Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients. Eur J Clin Pharmacol. 2009;65:1089\u201396. https:\/\/doi.org\/10.1007\/s00228-009-0728-2.","journal-title":"Eur J Clin Pharmacol"},{"key":"4317_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/jir.12101","volume":"58","author":"L Ferguson","year":"2014","unstructured":"Ferguson L, Murphy GH. The effects of training on the ability of adults with an intellectual disability to give informed consent to medication. J Intellect Disabil Res. 2014;58:864\u201373. https:\/\/doi.org\/10.1111\/jir.12101.","journal-title":"J Intellect Disabil Res"},{"key":"4317_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pec.2014.08.021","volume":"97","author":"JL Kuntz","year":"2014","unstructured":"Kuntz JL, Safford MM, Singh JA, Phansalkar S, Slight SP, Her QL, et al. Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings. Patient Educ Couns. 2014;97:310\u201326. https:\/\/doi.org\/10.1016\/j.pec.2014.08.021.","journal-title":"Patient Educ Couns"},{"key":"4317_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13063-023-07155-w","volume":"24","author":"S Nadolny","year":"2023","unstructured":"Nadolny S, Bruland D, Grunwald M, Gr\u00f6ndahl A, Grammatico J, Richter MT, et al. Case management and care expertise as a prevention approach for adults with intellectual disabilities (FaPP-MgB): study protocol for a randomized-controlled trial. Trials. 2023;24:136. https:\/\/doi.org\/10.1186\/s13063-023-07155-w.","journal-title":"Trials"},{"key":"4317_CR32","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/bmj.328.7455.1561","volume":"328","author":"P Hawe","year":"2004","unstructured":"Hawe P, Shiell A, Riley T. Complex interventions: how out of control can a randomised controlled trial be? BMJ. 2004;328:1561\u20133. https:\/\/doi.org\/10.1136\/bmj.328.7455.1561.","journal-title":"BMJ"},{"key":"4317_CR33","doi-asserted-by":"publisher","first-page":"e0264343","DOI":"10.1371\/journal.pone.0264343","volume":"17","author":"R Vos","year":"2022","unstructured":"Vos R, Boesten J, van den Akker M. Fifteen-year trajectories of Multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns. PLoS ONE. 2022;17:e0264343. https:\/\/doi.org\/10.1371\/journal.pone.0264343.","journal-title":"PLoS ONE"},{"key":"4317_CR34","doi-asserted-by":"publisher","first-page":"614825","DOI":"10.3389\/fpsyt.2021.614825","volume":"12","author":"S Lonchampt","year":"2021","unstructured":"Lonchampt S, Gerber F, Aubry J-M, Desmeules J, Kosel M, Besson M. Prevalence of polypharmacy and inappropriate medication in adults with intellectual disabilities in a hospital setting in Switzerland. Front Psychiatry. 2021;12:614825. https:\/\/doi.org\/10.3389\/fpsyt.2021.614825.","journal-title":"Front Psychiatry"},{"key":"4317_CR35","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101030","author":"AJ Doherty","year":"2020","unstructured":"Doherty AJ, Atherton H, Boland P, Hastings R, Hives L, Hood K, et al. Barriers and facilitators to primary health care for people with intellectual disabilities and\/or autism: an integrative review. BJGP Open. 2020. https:\/\/doi.org\/10.3399\/bjgpopen20X101030.","journal-title":"BJGP Open"},{"key":"4317_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-3-319-90083-4_18","volume-title":"Physical health of adults with intellectual and developmental disabilities","author":"B Marks","year":"2019","unstructured":"Marks B, Sisirak J, Heller T. Health promotion and people with intellectual disability. In: Prasher VP, Janicki MP, editors. Physical health of adults with intellectual and developmental disabilities. Cham: Springer International Publishing; 2019. pp. 359\u201379."},{"key":"4317_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/scs.12448","volume":"32","author":"AE Roll","year":"2018","unstructured":"Roll AE. Health promotion for people with intellectual disabilities - A concept analysis. Scand J Caring Sci. 2018;32:422\u20139. https:\/\/doi.org\/10.1111\/scs.12448.","journal-title":"Scand J Caring Sci"},{"key":"4317_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1024\/1861-6186\/a000582","volume":"15","author":"K Barre","year":"2020","unstructured":"Barre K, Boettcher AM, Sch\u00fc\u00dfler N, Weber P. Qualifizierung f\u00fcr innovative aufgaben in der Pflege. PADUA. 2020;15:297\u2013302. https:\/\/doi.org\/10.1024\/1861-6186\/a000582.","journal-title":"PADUA"},{"key":"4317_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/9781119966241","volume-title":"A practical guide to cluster randomised trials in health services research","author":"S Eldridge","year":"2012","unstructured":"Eldridge S, Kerry SM. A practical guide to cluster randomised trials in health services research. Chichester, West Sussex: Wiley; 2012."},{"key":"4317_CR40","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v085.i08","author":"D Uschner","year":"2018","unstructured":"Uschner D, Schindler D, Hilgers R-D, Heussen N. RandomizeR: an R package for the assessment and implementation of randomization in clinical trials. J Stat Soft. 2018. https:\/\/doi.org\/10.18637\/jss.v085.i08.","journal-title":"J Stat Soft"},{"key":"4317_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1365-2753.2009.01169.x","volume":"16","author":"C Mahler","year":"2010","unstructured":"Mahler C, Hermann K, Horne R, Ludt S, Haefeli WE, Szecsenyi J, Jank S. Assessing reported adherence to Pharmacological treatment recommendations. Translation and evaluation of the medication adherence report scale (MARS) in Germany. J Eval Clin Pract. 2010;16:574\u20139. https:\/\/doi.org\/10.1111\/j.1365-2753.2009.01169.x.","journal-title":"J Eval Clin Pract"},{"key":"4317_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08870440290001502","volume":"17","author":"R Horne","year":"2002","unstructured":"Horne R, Weinman J. Self-regulation and Self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining Non-adherence to preventer medication. Psychol Health. 2002;17:17\u201332. https:\/\/doi.org\/10.1080\/08870440290001502.","journal-title":"Psychol Health"},{"key":"4317_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10198-003-0182-5","volume":"4","author":"W Greiner","year":"2003","unstructured":"Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ. 2003;4:222\u201331. https:\/\/doi.org\/10.1007\/s10198-003-0182-5.","journal-title":"Eur J Health Econ"},{"key":"4317_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2753.2011.01636.x","volume":"18","author":"D Stange","year":"2012","unstructured":"Stange D, Kriston L, Langebrake C, Cameron LK, Wollacott JD, Baehr M, Dartsch DC. Development and psychometric evaluation of the German version of the medication regimen complexity index (MRCI-D). J Eval Clin Pract. 2012;18:515\u201322. https:\/\/doi.org\/10.1111\/j.1365-2753.2011.01636.x.","journal-title":"J Eval Clin Pract"},{"key":"4317_CR45","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun Y-T, Bailey MJ, Kong DCM, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369\u201376. https:\/\/doi.org\/10.1345\/aph.1D479.","journal-title":"Ann Pharmacother"},{"key":"4317_CR46","unstructured":"Ustun TB, Kostanjesek N, Chatterji S, Rehm J. World Health Organization (WHO). Measuring health and disability: manual for WHO disability assessment schedule (WHODAS 2.0). Geneva: World Health Organization (WHO); 2010."},{"key":"4317_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149\u201360. https:\/\/doi.org\/10.3758\/BRM.41.4.1149.","journal-title":"Behav Res Methods"},{"key":"4317_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2165\/00002512-200825060-00001","volume":"25","author":"CM Hughes","year":"2008","unstructured":"Hughes CM. Compliance with medication in nursing homes for older people: resident enforcement or resident empowerment? Drugs Aging. 2008;25:445\u201354. https:\/\/doi.org\/10.2165\/00002512-200825060-00001.","journal-title":"Drugs Aging"},{"key":"4317_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1748-3743.2010.00264.x","volume":"6","author":"C Parsons","year":"2011","unstructured":"Parsons C, Lapane K, Kerse N, Hughes C. Prescribing for older people in nursing homes: a review of the key issues. Int J Older People Nurs. 2011;6:45\u201354. https:\/\/doi.org\/10.1111\/j.1748-3743.2010.00264.x.","journal-title":"Int J Older People Nurs"},{"key":"4317_CR50","unstructured":"Park J. Selbstbestimmtes Leben f\u00fcr Menschen mit geistiger Behinderung im betreuten Wohnen [Dissertation]. Marburg: Philipps-Universit\u00e4t Marburg; 2014."},{"key":"4317_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00391-019-01533-3","volume":"52","author":"A Thimm","year":"2019","unstructured":"Thimm A, Dieckmann F, Ha\u00dfler T. In which residential settings do older persons with intellectual disability live? A quantitative comparison of age groups for Westphalia-Lippe. Z Gerontol Geriatr. 2019;52:220\u20137. https:\/\/doi.org\/10.1007\/s00391-019-01533-3.","journal-title":"Z Gerontol Geriatr"},{"key":"4317_CR52","unstructured":"Maetzel J, Heimer A, Braukmann J, Frankenbach P, Ludig L, Schmutz S. Dritter Teilhabebericht der bundesregierung \u00fcber die lebenslagen von menschen Mit Beeintr\u00e4chtigungen: Teilhabe - Beeintr\u00e4chtigung - Behinderung. Bonn: Bundesministerium f\u00fcr Arbeit und Soziales, Referat Information, Monitoring, B\u00fcrgerservice, Bibliothek; 2021."},{"key":"4317_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.gerinurse.2010.05.004","volume":"31","author":"E Gould","year":"2010","unstructured":"Gould E, Mitty E. Medication adherence is a partnership, medication compliance is not. Geriatr Nurs. 2010;31:290\u20138. https:\/\/doi.org\/10.1016\/j.gerinurse.2010.05.004.","journal-title":"Geriatr Nurs"},{"key":"4317_CR54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bcp.12194","volume":"77","author":"T-M-U Nguyen","year":"2014","unstructured":"Nguyen T-M-U, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2014;77:427\u201345. https:\/\/doi.org\/10.1111\/bcp.12194.","journal-title":"Br J Clin Pharmacol"},{"key":"4317_CR55","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.sapharm.2015.09.008","volume":"12","author":"I Patel","year":"2016","unstructured":"Patel I, Erickson SR, Caldwell CH, Woolford SJ, Bagozzi RP, Chang J, Balkrishnan R. Predictors of medication adherence and persistence in medicaid enrollees with developmental disabilities and type 2 diabetes. Res Social Adm Pharm. 2016;12:592\u2013603. https:\/\/doi.org\/10.1016\/j.sapharm.2015.09.008.","journal-title":"Res Social Adm Pharm"},{"key":"4317_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1352\/1944-7558-124.3.248","volume":"124","author":"AC Cyrus","year":"2019","unstructured":"Cyrus AC, Royer J, Carroll DD, Courtney-Long EA, McDermott S, Turk MA. Anti-Hypertensive medication use and factors related to adherence among adults with intellectual and developmental disabilities. Am J Intellect Dev Disabil. 2019;124:248\u201362. https:\/\/doi.org\/10.1352\/1944-7558-124.3.248.","journal-title":"Am J Intellect Dev Disabil"},{"key":"4317_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.dhjo.2013.02.003","volume":"6","author":"JL Vacek","year":"2013","unstructured":"Vacek JL, Hunt SL, Shireman T. Hypertension medication use and adherence among adults with developmental disability. Disabil Health J. 2013;6:297\u2013302. https:\/\/doi.org\/10.1016\/j.dhjo.2013.02.003.","journal-title":"Disabil Health J"},{"key":"4317_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ridd.2016.03.014","volume":"55","author":"RJ Zaal","year":"2016","unstructured":"Zaal RJ, Ebbers S, Borms M, de Koning B, Mombarg E, Ooms P, et al. Medication review using a systematic tool to reduce inappropriate prescribing (STRIP) in adults with an intellectual disability: A pilot study. Res Dev Disabil. 2016;55:132\u201342. https:\/\/doi.org\/10.1016\/j.ridd.2016.03.014.","journal-title":"Res Dev Disabil"},{"key":"4317_CR59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/13668250.2017.1350836","volume":"43","author":"SR Erickson","year":"2018","unstructured":"Erickson SR, Nicaj D, Barron S. Complexity of medication regimens of people with intellectual and developmental disabilities. J Intellect Dev Disabil. 2018;43:351\u201361. https:\/\/doi.org\/10.3109\/13668250.2017.1350836.","journal-title":"J Intellect Dev Disabil"},{"key":"4317_CR60","doi-asserted-by":"publisher","first-page":"e010505","DOI":"10.1136\/bmjopen-2015-010505","volume":"6","author":"M O\u2019Dwyer","year":"2016","unstructured":"O\u2019Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 2016;6:e010505. https:\/\/doi.org\/10.1136\/bmjopen-2015-010505.","journal-title":"BMJ Open"},{"key":"4317_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bcp.13479","volume":"84","author":"J O\u2019Connell","year":"2018","unstructured":"O\u2019Connell J, Burke \u00c9, Mulryan N, O\u2019Dwyer C, Donegan C, McCallion P, et al. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: an observational cross-sectional study. Br J Clin Pharmacol. 2018;84:553\u201367. https:\/\/doi.org\/10.1111\/bcp.13479.","journal-title":"Br J Clin Pharmacol"},{"key":"4317_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/13668250.2013.778968","volume":"38","author":"TN Doan","year":"2013","unstructured":"Doan TN, Lennox NG, Taylor-Gomez M, Ware RS. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study. J Intellect Dev Disabil. 2013;38:177\u201381. https:\/\/doi.org\/10.3109\/13668250.2013.778968.","journal-title":"J Intellect Dev Disabil"},{"key":"4317_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2788.2010.01275.x","volume":"54","author":"G de Kuijper","year":"2010","unstructured":"de Kuijper G, Hoekstra P, Visser F, Scholte FA, Penning C, Evenhuis H. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the netherlands: prevalence and reasons for prescription. J Intellect Disabil Res. 2010;54:659\u201367. https:\/\/doi.org\/10.1111\/j.1365-2788.2010.01275.x.","journal-title":"J Intellect Disabil Res"},{"key":"4317_CR64","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/jir.12305","volume":"60","author":"M Henman","year":"2016","unstructured":"Henman M, O\u2019Dwyer M, Paruk M, Connell M. Complexity of medication use in people with intellectual disabilities.: IASSIDD world Congress, Melbourne. J Intellect Disabil Res. 2016;60:681. https:\/\/doi.org\/10.1111\/jir.12305.","journal-title":"J Intellect Disabil Res"},{"key":"4317_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1362361317709970","volume":"22","author":"Y Saqr","year":"2018","unstructured":"Saqr Y, Braun E, Porter K, Barnette D, Hanks C. Addressing medical needs of adolescents and adults with autism spectrum disorders in a primary care setting. Autism. 2018;22:51\u201361. https:\/\/doi.org\/10.1177\/1362361317709970.","journal-title":"Autism"}],"container-title":["BMC Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12912-026-04317-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-04317-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-04317-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:43:41Z","timestamp":1781631821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12912-026-04317-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1186\/s12912-026-04317-4","relation":{},"ISSN":["1472-6955"],"issn-type":[{"value":"1472-6955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods in this study were performed in accordance with the Declaration of Helsinki. This study was reviewed and approved by the ethics committee of the Competence Center Gesundheit (CCG, approval number 2018-11). Written and verbal informed consent has been obtained from the client and additionally from the legal guardian, if applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}